These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36982396)
21. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor. Molnár F; Sigüeiro R; Sato Y; Araujo C; Schuster I; Antony P; Peluso J; Muller C; Mouriño A; Moras D; Rochel N PLoS One; 2011 Mar; 6(3):e18124. PubMed ID: 21483824 [TBL] [Abstract][Full Text] [Related]
22. Effects of vitamin D3 and its chemical analogs on the growth of Hodgkin's lymphoma, in vitro. Gharbaran R; Zhang B; Valerio L; Onwumere O; Wong M; Mighty J; Redenti S BMC Res Notes; 2019 Apr; 12(1):216. PubMed ID: 30961641 [TBL] [Abstract][Full Text] [Related]
23. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation. Mashaqbeh H; Obaidat R; Al-Shar'i N Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic Potential of a Novel Vitamin D Alshabrawy AK; Cui Y; Sylvester C; Yang D; Petito ES; Barratt KR; Sawyer RK; Heatlie JK; Polara R; Sykes MJ; Atkins GJ; Hickey SM; Wiese MD; Stringer AM; Liu Z; Anderson PH Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883516 [TBL] [Abstract][Full Text] [Related]
25. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. Barry EL; Rees JR; Peacock JL; Mott LA; Amos CI; Bostick RM; Figueiredo JC; Ahnen DJ; Bresalier RS; Burke CA; Baron JA J Clin Endocrinol Metab; 2014 Oct; 99(10):E2133-7. PubMed ID: 25070320 [TBL] [Abstract][Full Text] [Related]
26. Metabolism and Action of 25-Hydroxy-19-nor-Vitamin D₃ in Human Prostate Cells. Munetsuna E; Kittaka A; Chen TC; Sakaki T Vitam Horm; 2016; 100():357-77. PubMed ID: 26827959 [TBL] [Abstract][Full Text] [Related]
28. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Osborne JE; Hutchinson PE Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089 [TBL] [Abstract][Full Text] [Related]
29. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor. Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643 [TBL] [Abstract][Full Text] [Related]
31. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines. Zhuang SH; Schwartz GG; Cameron D; Burnstein KL Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366 [TBL] [Abstract][Full Text] [Related]
32. Nanosponge Carriers- An Archetype Swing in Cancer Therapy: A Comprehensive Review. Osmani RA; Hani U; Bhosale RR; Kulkarni PK; Shanmuganathan S Curr Drug Targets; 2017; 18(1):108-118. PubMed ID: 26424399 [TBL] [Abstract][Full Text] [Related]
33. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990 [TBL] [Abstract][Full Text] [Related]
34. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
35. Epigenetics Predicts Serum 25-Hydroxyvitamin D Response to Vitamin D Chen L; Dong Y; Chen J; Huang Y; Zhu H Mol Nutr Food Res; 2020 Jan; 64(1):e1900738. PubMed ID: 31667917 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges. Rao MRP; Shirsath C AAPS PharmSciTech; 2017 Jul; 18(5):1728-1738. PubMed ID: 27757921 [TBL] [Abstract][Full Text] [Related]
37. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. Ansari KA; Vavia PR; Trotta F; Cavalli R AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574 [TBL] [Abstract][Full Text] [Related]
38. Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways. Chang PL; Lee TF; Garretson K; Prince CW Clin Exp Metastasis; 1997 Nov; 15(6):580-92. PubMed ID: 9344042 [TBL] [Abstract][Full Text] [Related]
39. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers. de Medeiros Cavalcante IG; Silva AS; Costa MJ; Persuhn DC; Issa CT; de Luna Freire TL; da Conceição Rodrigues Gonçalves M Exp Gerontol; 2015 Jun; 66():10-6. PubMed ID: 25827670 [TBL] [Abstract][Full Text] [Related]